We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Peripheral Arteriopathy Rate In Stroke (PARIS)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00794066
First Posted: November 19, 2008
Last Update Posted: November 4, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Erlangen-Nürnberg Medical School
  Purpose

Purpose:

To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.

Interventions:

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Design:

Prospective, open, cohort study.

Study size planned:

1500.

Follow-up duration:

3 months.


Condition Intervention
Peripheral Artery Disease Procedure: measuring the ankle brachial index

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients

Resource links provided by NLM:


Further study details as provided by University of Erlangen-Nürnberg Medical School:

Primary Outcome Measures:
  • Functional outcome (modified Rankin Scale) [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • Prevalence of peripheral arterial disease [ Time Frame: during hospital stay ]
    Presence or not of PAD as assessed using ABI during hospital stay


Estimated Enrollment: 1500
Study Start Date: August 2008
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
TIA
Procedure: measuring the ankle brachial index
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
2
Ischemic stroke
Procedure: measuring the ankle brachial index
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
3
Hemorrhagic stroke
Procedure: measuring the ankle brachial index
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
consecutive patients with acute ischemic or hemorhagic stroke.
Criteria

Inclusion Criteria:

  • All consecutive adult patients with acute ischemic or hemorrhagic stroke.

Exclusion Criteria:

  • Congestive heart failure.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00794066


Locations
Germany
Department of Neurology, University of Erlangen, Germany
Erlangen, Germany, 91054
Sponsors and Collaborators
University of Erlangen-Nürnberg Medical School
Investigators
Study Director: Stefan Schwab, MD Head of the Department of Neurology, University of Erlangen, Germany
  More Information

Responsible Party: University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier: NCT00794066     History of Changes
Other Study ID Numbers: PARIS-Study2009
First Submitted: November 18, 2008
First Posted: November 19, 2008
Last Update Posted: November 4, 2016
Last Verified: November 2016

Keywords provided by University of Erlangen-Nürnberg Medical School:
PAD
Stroke
ICH
prevalence

Additional relevant MeSH terms:
Peripheral Arterial Disease
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Peripheral Vascular Diseases


To Top